Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India: Which Stock Should You Track
- September 24, 2026
- Posted by: Lakshit Sharma
- Category: Market
Rossari Biotech PE 16.69, mkt cap Rs 2,516 crore. Neogen Chemicals PE 201.77, mkt cap Rs 7,177 crore. Anupam Rasayan India PE 60.37, mkt cap Rs 13,581 crore.
Quick Answer
Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India is a side-by-side comparison of three companies from the Specialty Chemicals (Fresh Set 2) space. On this comparison, Rossari Biotech carries a market capitalisation of about Rs 2,516 crore against Rs 7,177 crore for Neogen Chemicals and Rs 13,581 crore for Anupam Rasayan India, with return on equity of 11.19%, 3.52% and 5.10% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India starts with the core numbers most investors compare within the Specialty Chemicals (Fresh Set 2) segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Specialty Chemicals (Fresh Set 2) bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Rossari Biotech, Neogen Chemicals and Anupam Rasayan India: Company Overview
Rossari Biotech is a listed Indian company in the Specialty Chemicals (Fresh Set 2) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Neogen Chemicals is a listed Indian company in the Specialty Chemicals (Fresh Set 2) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Anupam Rasayan India is a listed Indian company in the Specialty Chemicals (Fresh Set 2) space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India: Valuation and Profitability Snapshot
| Metric | Rossari Biotech | Neogen Chemicals | Anupam Rasayan India |
|---|---|---|---|
| Market Cap (approx.) | Rs 2,516 crore | Rs 7,177 crore | Rs 13,581 crore |
| PE Ratio (TTM) | 16.69 | 201.77 | 60.37 |
| PB Ratio | 1.89 | 4.55 | 4.11 |
| Return on Equity (ROE) | 11.19% | 3.52% | 5.10% |
| EPS (TTM, Rs) | 27.21 | 11.84 | 19.76 |
| Dividend Yield | 0.11% | 0.07% | 0.13% |
| Debt to Equity | 0.33 | 1.71 | 0.56 |
| Book Value per Share (Rs) | 240.70 | 525.01 | 290.02 |
Check the Univest Screener for Live Data
On valuation, Rossari Biotech trades at a PE of 16.69 and a PB of 1.89, Neogen Chemicals at a PE of 201.77 and a PB of 4.55, while Anupam Rasayan India trades at a PE of 60.37 and a PB of 4.11. On return on equity, the three post 11.19%, 3.52% and 5.10% respectively, and on dividend yield they stand at 0.11%, 0.07% and 0.13%.
Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Rossari Biotech | Rs 700.39 crore | Rs 35.10 crore | +28.5% | -0.5% |
| Neogen Chemicals | Rs 254.15 crore | Rs 17.11 crore | +35.3% | +2.7% |
| Anupam Rasayan India | Rs 667.55 crore | Rs 51.22 crore | +36.0% | +4.4% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY28, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Rossari Biotech, Neogen Chemicals and Anupam Rasayan India live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three specialty chemicals (fresh set 2) names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India highlights how differently three companies in the same specialty chemicals (fresh set 2) segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Rossari Biotech vs Neogen Chemicals vs Anupam Rasayan India
What is the market cap difference between Rossari Biotech, Neogen Chemicals and Anupam Rasayan India?
Ans. As of September 2026, Rossari Biotech has a market cap of approximately Rs 2,516 crore, Neogen Chemicals is at approximately Rs 7,177 crore, and Anupam Rasayan India is at approximately Rs 13,581 crore.
Which of the three has the highest PE ratio?
Ans. Among Rossari Biotech, Neogen Chemicals and Anupam Rasayan India, the PE ratios stand at 16.69, 201.77 and 60.37 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Rossari Biotech, Neogen Chemicals and Anupam Rasayan India post ROE of 11.19%, 3.52% and 5.10% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Rossari Biotech, Neogen Chemicals and Anupam Rasayan India carry dividend yields of 0.11%, 0.07% and 0.13% respectively.
What is the debt to equity ratio for Rossari Biotech, Neogen Chemicals and Anupam Rasayan India?
Ans. Rossari Biotech carries a debt to equity of 0.33, Neogen Chemicals of 1.71, and Anupam Rasayan India of 0.56.
Which of the three trades at the highest price to book value?
Ans. Rossari Biotech, Neogen Chemicals and Anupam Rasayan India trade at price to book ratios of 1.89, 4.55 and 4.11 respectively.
Is one of Rossari Biotech, Neogen Chemicals or Anupam Rasayan India better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.